Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014, Article ID 834136, 6 pages
http://dx.doi.org/10.1155/2014/834136
Research Article

Incidence and Survival Analysis of Gastrointestinal Stromal Tumors in Shanghai: A Population-Based Study from 2001 to 2010

1Department of Biostatistics, Fudan University, Shanghai 200032, China
2Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China

Received 23 October 2013; Revised 24 March 2014; Accepted 25 March 2014; Published 23 April 2014

Academic Editor: Edoardo Giovanni Giannini

Copyright © 2014 Minzhi Lv et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Zhao and C. Yue, “Gastrointestinal stromal tumor,” Journal of Gastrointestinal Oncology, vol. 3, no. 3, pp. 189–208, 2012. View at Google Scholar
  2. B. Liegl-Atzwanger, J. A. Fletcher, and C. D. M. Fletcher, “Gastrointestinal stromal tumors,” Virchows Archiv, vol. 456, no. 2, pp. 111–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. Trent and R. S. Benjamin, “New developments in gastrointestinal stromal tumor,” Current Opinion in Oncology, vol. 18, no. 4, pp. 386–395, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. G. D. Demetri, M. von Mehren, C. R. Antonescu et al., “NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors,” Journal of the National Comprehensive Cancer Network, supplement 2, pp. S1–S41, 2010. View at Google Scholar
  5. M. Miettinen and J. Lasota, “Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis,” Archives of Pathology and Laboratory Medicine, vol. 130, no. 10, pp. 1466–1478, 2006. View at Google Scholar · View at Scopus
  6. R. M. Mostafa, Y. M. Moustafa, and H. Hamdy, “Interstitial cells of Cajal, the Maestro in health and disease,” World Journal of Gastroenterology, vol. 16, no. 26, pp. 3239–3248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. D'Adamo, “Advances in the treatment of gastrointestinal stromal tumor,” Advances in Therapy, vol. 26, no. 9, pp. 826–837, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Nilsson, P. Bümming, J. M. Meis-Kindblom et al., “Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden,” Cancer, vol. 103, no. 4, pp. 821–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Tryggvason, H. G. Gíslason, M. K. Magnússon, and J. G. Jónasson, “Gastrointestinal stromal tumors in Iceland, 1990–2003: the Icelandic GIST study, a population-based incidence and pathologic risk stratification study,” International Journal of Cancer, vol. 117, no. 2, pp. 289–293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. W. G. Goettsch, S. D. Bos, N. Breekveldt-Postma, M. Casparie, R. M. C. Herings, and P. C. W. Hogendoorn, “Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study,” European Journal of Cancer, vol. 41, no. 18, pp. 2868–2872, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Mucciarini, G. Rossi, F. Bertolini et al., “Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study,” BMC Cancer, vol. 7, article 230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Rubió, R. Marcos-Gragera, M. R. Ortiz et al., “Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain,” European Journal of Cancer, vol. 43, no. 1, pp. 144–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Tran, J. A. Davila, and H. B. El-Serag, “The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000,” American Journal of Gastroenterology, vol. 100, no. 1, pp. 162–168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Monges, S. Bisot-Locard, J.-Y. Blay et al., “The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists,” Bulletin du Cancer, vol. 97, no. 3, pp. E16–E22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Gastrointestinal stromal tumors, “ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 23, 7, pp. vii49–vii55, 2012. View at Publisher · View at Google Scholar
  16. G. D. Demetri, M. Von Mehren, C. D. Blanke et al., “Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors,” The New England Journal of Medicine, vol. 347, no. 7, pp. 472–480, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. C. D. Blanke, G. D. Demetri, M. Von Mehren et al., “Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT,” Journal of Clinical Oncology, vol. 26, no. 4, pp. 620–625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Verweij, P. G. Casali, J. Zalcberg et al., “Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial,” The Lancet, vol. 364, no. 9440, pp. 1127–1134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. R. P. DeMatteo, K. V. Ballman, C. R. Antonescu et al., “Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 373, no. 9669, pp. 1097–1104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Shanghai Municipal Statistics Bureau, Shanghai Statistical Yearbook, China Statistics Press, 2011.
  21. O. B. Ahmad et al., 2005, Age standardization of rates: a new WHO standard.
  22. B. M. Yan, G. G. Kaplan, S. Urbanski, C. L. Nash, and P. L. Beck, “Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based study,” International Journal of Surgical Pathology, vol. 16, no. 3, pp. 241–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M.-Y. Cho, J. H. Sohn, J. M. Kim et al., “Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003–2004,” Journal of Korean Medical Science, vol. 25, no. 6, pp. 853–862, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. N. J. Chiang, L.-T. Chen, C.-R. Tsai et al., “The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998–2008: a nation-wide cancer registry-based study,” BMC Cancer, vol. 14, no. 1, p. 102, 2014. View at Publisher · View at Google Scholar
  25. M. Miettinen, L. H. Sobin, and J. Lasota, “Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up,” American Journal of Surgical Pathology, vol. 29, no. 1, pp. 52–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. E. A. Perez, A. S. Livingstone, D. Franceschi et al., “Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors,” Journal of the American College of Surgeons, vol. 202, no. 4, pp. 623–629, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Agaimy, P. H. Wünsch, F. Hofstaedter et al., “Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) are common in adults and frequently show c-KIT mutations,” American Journal of Surgical Pathology, vol. 31, no. 1, pp. 113–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. R. P. DeMatteo, J. J. Lewis, D. Leung, S. S. Mudan, J. M. Woodruff, and M. F. Brennan, “Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival,” Annals of Surgery, vol. 231, no. 1, pp. 51–58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Tran, J. A. Davila, and H. B. El-Serag, “The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000,” American Journal of Gastroenterology, vol. 100, no. 1, pp. 162–168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. W. Call, C. D. Walentas, J. C. Eickhoff, and N. J. Scherzer, “Survival of gastrointestinal stromal tumor patients in the Imatinib era: life raft group observational registry,” BMC Cancer, vol. 12, p. 90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Miettinen and J. Lasota, “Gastrointestinal stromal tumors: pathology and prognosis at different sites,” Seminars in Diagnostic Pathology, vol. 23, no. 2, pp. 70–83, 2006. View at Publisher · View at Google Scholar · View at Scopus